3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Prostatic Neoplasms
3
Pain
3
Neoplasms
3
Colorectal Neoplasms
3
Sleep Initiation and Maintenance Disorders
2
Polycystic Ovary Syndrome
2
Osteosarcoma
2
Head and Neck Neoplasms
2
Depression
2
Carcinoma, Non-Small-Cell Lung
2
Breast Neoplasms
2
Anxiety Disorders
2
Acupuncture
2
Xerostomia
1
Vomiting
1
Urinary Incontinence, Stress
1
Urinary Incontinence
1
Testicular Neoplasms
1
Teratoma
1
Sarcoma, Ewing
1
Sarcoma
1
Salivary Gland Neoplasms
1
Rectal Neoplasms
1
Radiation Injuries
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Postoperative Nausea and Vomiting
1
Postoperative Ileus
1
Postoperative Complications
1
Pancreatic Neoplasms
1
PGS
1
Interventions
Bupivacaine
5
Anesthesia, Local
5
Anesthesia, General
5
Morphine
4
Dexmedetomidine
4
Acupuncture Therapy
4
parecoxib
3
Transcutaneous Electric Nerve Stimulation
3
Saline Solution
3
Ropivacaine
3
Radiofrequency Ablation
2
Pregabalin
2
Fentanyl
2
Ethanol
2
Dental Occlusion
2
Control Groups
2
Anesthetics, Local
2
Anesthesia, Spinal
2
Anesthesia, Conduction
2
Analgesics, Opioid
2
loxoprofen
1
engage 8200
1
Yoga
1
Uterine Myomectomy
1
Transcranial Magnetic Stimulation
1
Transcranial Direct Current Stimulation
1
Tramadol
1
Touch
1
Therapeutics
1
Telemedicine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Agnosia
×
Electroacupuncture
×
Clear all
NCT04917796
2026-01-30
ACT
Dana-Farber Cancer Institute
Phase NA
Active not recruiting
255 enrolled